Showing results (51-60 of 71) with videos related to
Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry Letters|August 28, 2003
Macrocyclic bisindolylmaleimides as inhibitors of protein kinase C and glycogen synthase kinase-3Han-Cheng Zhang, Kimberly B White, Hong Ye, et al.Journal of Medicinal Chemistry|December 28, 2007
7-fluoroindazoles as potent and selective inhibitors of factor XaYu-Kai Lee, Daniel J Parks, Tianbao Lu, et al.Journal of Medicinal Chemistry|March 17, 2007
Discovery of potent, selective, orally active, nonpeptide inhibitors of human mast cell chymaseMichael N Greco, Michael J Hawkins, Eugene T Powell, et al.Bioorganic & Medicinal Chemistry|August 23, 2005
Aza-bicyclic amino acid carboxamides as alpha4beta1/alpha4beta7 integrin receptor antagonistsAlexey B Dyatkin, Yong Gong, Tamara A Miskowski, et al.Journal of Medicinal Chemistry|March 18, 2005
In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug designMichael J Costanzo, Harold R Almond, Leonard R Hecker, et al.Bioorganic & Medicinal Chemistry Letters|October 19, 2007
Next-generation spirobenzazepines: identification of RWJ-676070 as a balanced vasopressin V1a/V2 receptor antagonist for human clinical studiesMin Amy Xiang, Philip J Rybczynski, Mona Patel, et al.The Journal of Organic Chemistry|February 19, 2008
Suzuki-Miyaura approach to JNJ-26076713, an orally active tetrahydroquinoline-containing alphaVbeta3/alphaVbeta5 integrin antagonist. enantioselective synthesis and stereochemical studiesWilliam A Kinney, Christopher A Teleha, Andrew S Thompson, et al.Bioorganic & Medicinal Chemistry Letters|May 6, 2004
Potent nonpeptide vasopressin receptor antagonists based on oxazino- and thiazinobenzodiazepine templatesJay M Matthews, William J Hoekstra, Alexey B Dyatkin, et al.Nature Biotechnology|June 17, 2020
Directed remodeling of the mouse gut microbiome inhibits the development of atherosclerosisPoshen B Chen, Audrey S Black, Adam L Sobel, et al.Bioorganic & Medicinal Chemistry Letters|May 20, 2004
3-(7-Azaindolyl)-4-arylmaleimides as potent, selective inhibitors of glycogen synthase kinase-3Han-Cheng Zhang, Hong Ye, Bruce R Conway, et al.Pageof 8